Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 33 |
| Gross Profit | N/A | N/A | N/A | N/A | 33 |
| Operating Expenses | 11,127 | 11,337 | 7,687 | 5,680 | 3,894 |
| Operating Income | -11,127 | -11,337 | -7,687 | -5,680 | -3,861 |
| Other Income | 62 | 19 | 51 | 166 | 6 |
| Pre-tax Income | -11,065 | -11,318 | -7,636 | -5,514 | -3,855 |
| Net Income Continuous | -11,065 | -11,318 | -7,636 | -5,514 | -3,855 |
| Net Income | $-11,065 | $-11,318 | $-7,636 | $-5,514 | $-3,855 |
| EPS Basic Total Ops | -0.11 | -0.21 | -0.14 | -0.31 | -0.33 |
| EPS Basic Continuous Ops | -0.12 | -0.21 | -0.14 | -0.31 | -0.34 |
| EPS Diluted Total Ops | -0.11 | -0.21 | -0.14 | -0.31 | -0.33 |
| EPS Diluted Continuous Ops | -0.12 | -0.21 | -0.14 | -0.31 | -0.34 |
| EBITDA(a) | $-11,019 | $-11,281 | $-7,653 | $-5,826 | $-3,859 |